Your browser doesn't support javascript.
loading
Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults.
Aguilar-Ramirez, Diego; Herrington, William G; Alegre-Díaz, Jesus; Staplin, Natalie; Ramírez-Reyes, Raúl; Gnatiuc, Louisa Friedrichs; Hill, Michael; Romer, Frederik; Trichia, Eirini; Bragg, Fiona; Wade, Rachel; Lewington, Sarah; Collins, Rory; Emberson, Jonathan R; Kuri-Morales, Pablo; Tapia-Conyer, Roberto.
Afiliação
  • Aguilar-Ramirez D; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Herrington WG; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Alegre-Díaz J; Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Staplin N; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Ramírez-Reyes R; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Gnatiuc LF; Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Hill M; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Romer F; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Trichia E; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Bragg F; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Wade R; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Lewington S; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Collins R; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Emberson JR; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Kuri-Morales P; MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Tapia-Conyer R; Clinical Trial Service Unit & Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Commun Med (Lond) ; 2(1): 143, 2022 Nov 14.
Article em En | MEDLINE | ID: mdl-36376486
Obesity increases the risk of multiple diseases, in part due to alterations in how the body breaks down carbohydrates and fats, which is reflected in molecules that circulate in blood. In obesity, disease risk may vary depending on whether fat accumulates in the body overall (i.e. total adiposity), in the middle of the body (i.e. abdominal adiposity) or around the hips (i.e. gluteo-femoral adiposity). Here, we show that in a population of Mexican adults higher total and abdominal adiposity relate adversely, while higher gluteo-femoral adiposity relates favourably, to numerous molecules in blood that are linked to type 2 diabetes and heart disease. These findings provide insight on the processes that link the accumulation of fat across the body with disease risk in a population where obesity rates are high.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE País/Região como assunto: Mexico Idioma: En Ano de publicação: 2022 Tipo de documento: Article